Navigation Links
Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Date:8/19/2007

NEW YORK, Aug. 8 /PRNewswire-FirstCall/ -- Xenomics, Inc. (the "Company") (Pink Sheets: XNOM; FWB: XE7) a developer of next-generation medical DNA diagnostic technologies, announced today that its first diagnostic test developed for stratification of patients with Acute Myeloid Leukemia (AML) has been implemented at CLIA approved BRT Laboratories Inc. in Baltimore, Maryland, and is available for clinicians.

AML is the most common form of acute leukemia with about 13,400 new cases expected in 2007 in the USA and a similar number in Europe. Early detection of AML subtypes is important for development of a treatment strategy. The new test is based on a recent discovery of Drs. Falini and Mecucci at the Institute of Hematology at the University of Perugia in Italy that mutations in a nucleophosmin (NPM1) gene are characteristic of 30-40% of the cases of AML. NPM1 is a protein involved in regulation of ribosome biogenesis, cell division, cell death, and other important processes. Xenomics has obtained an exclusive license for the invention and developed a test that detects all 45 known mutations of NPM1 in a single reaction. The results will help physicians with prognosis, therapy, and monitoring of the disease. Stratification of AML patients is also necessary for anti-AML drug clinical trials.

"We are glad to work with Xenomics on AML diagnostics and to add this test to our repertoire of genetic tests" commented Antonette Allen, Clinical Service Manager of BRT Laboratories. "We believe that the NPM1 diagnostic test will not only help hematologists in the treatment of the disease but also in developing a test for monitoring the disease and patient response to anti-tumor therapy".

About Xenomics, Inc.

Xenomics is a molecular diagnostics company that focuses on the development of DNA-based tests using Transrenal DNA (Tr-DNA). Xenomics' patented technology uses safe and simple urine collection and can be applied to a broad range of application
'/>"/>

SOURCE Xenomics, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ewswire/ -- Bend Research Inc., a company,with mor...ve pharmaceutical,technologies to help clients sol...roblems, announced today that it has entered into ...orated, a global biotechnology company,headquarter...ollaboration, Vertex will utilize Bend,s formulati...
(Date:11/9/2009)...wswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT... pathologists, oncologists and the pharmaceutical ...make presentations at two upcoming investor confer...on will be made at the Lazard Capital Markets Sixt...uesday, November 17. The conference will be held a...
(Date:11/7/2009)...wire/ -- Patients reported C1-esterase inhibitor (...ating acute swelling attacks at any body location ...rding to data presented today at the 2009 American...I) Annual Meeting. The results come from a self-re...th the ongoing, prospective, open label I nternat...
Breaking Medicine Technology:Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 2Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 3Clarient to Present at Upcoming Healthcare Investor Conferences in New York City 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3Viral Genetics Completes Second Major Debt Conversion 55463 1Viral Genetics Completes Second Major Debt Conversion 55463 2Viral Genetics Completes Second Major Debt Conversion 55463 3Spokane Washington Man Indicted On Civil Rights Charges Related to Threats to Reproductive Health Services Clinic 55460 1Council for American Medical Innovation Honors Health Champion Senator Edward M Kennedy 55457 1Council for American Medical Innovation Honors Health Champion Senator Edward M Kennedy 55457 2Council for American Medical Innovation Honors Health Champion Senator Edward M Kennedy 55457 3
...le with Diabetes, Hospital,and Professional Charge...URGH, April 02, 2007 /PRNewswire-FirstCall/ -- The...ced today the,release of a new report on the preva...ype 2 diabetes. The inaugural Pittsburgh Type,2 Di...ient,demographics, hospital and professional charg...
...r 3, 2007 - Repros,Therapeutics Inc. (NasdaqGM:RPR... of Proellex(TM), an oral drug being developed to,...uggests that,treatment with Proellex results in a ...mptoms associated with uterine,fibroids and is gen..., This 12 week, double-blind study compared two do...
Other Medicine Technology:State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 2State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 3State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 4Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 2Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 3Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 4Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 5
(Date:11/9/2009)... 2009 Shire plc (LSE: SHP, NASDAQ: SHPGY), the gl...nounced the availability of INTUNIV (guanfacine) E...nited States for the treatment of Attention-Defici...olescents ages 6 to 17. INTUNIV, a once-daily for...cheduled alpha-2A receptor agonist approved for th...
(Date:11/9/2009)...ple around the world suffer from cataracts. Thomas...his coauthors discuss cataract surgery with the im...sue of Deutsches rzteblatt International ( Dtsch...ndness is usually due to opacification of the lens...rations are performed each year. Cataracts can be ...
(Date:11/9/2009)... people have tried to read Charles Darwin,s "Origi...0th anniversary this month, but gave up. , For t...k is about, help by way of a new book is at hand. ...eznick is the author of "The Origin Then and N...s " (Princeton University Press, 2009), which mak...
(Date:11/9/2009)...n bias might be the reason why African Americans a...e same rate as similar patients in other racial gr...pancreas transplantation at Georgetown University ...rgetown University Medical Center, and colleagues ...he American Journal of Transplantation . , Med...
(Date:11/9/2009)...risks, but not all agree , , MONDAY, Nov...ine solution might have soothing short-term benefi...nfections in the long run by stripping your nose o...ose, we are removing the bad mucus but, unfortunat...ains the antimicrobial agents as well," said Dr. T...
Breaking Medicine News(10 mins):Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 3Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 4Health News:Book by UC Riverside biologist explains Darwin's 'Origin of Species' 2Health News:Physician bias might keep life-saving transplants from black and Hispanic patients 2Health News:Sinus Rinses May Do More Harm Than Good 2Health News:Sinus Rinses May Do More Harm Than Good 3
...s begun the second reading of the controversial Me...t's third attempt in eight years to reform the 198...sting legislation on the matter to ensure that pat...hospital will be subject to community treatment or...
...e Group (AMARRG), Dr David Rivett, today congratul...e extension of emergency// medical training as par...and providing more support for GPs to participate....ns on an otherwise positive initiative. The...
...e sources, is touted as a more eco-friendly fuel, ... widespread// use of ethanol could actually pose a... fuel, may not be that eco-friendly after all. The...tmospheric scientist Mark Z. Jacobson says that if...
...ations portraying overall statistics of patients r.../. ART for AIDS has certainly reached many, though...e left out. As per the recent figures, it is...mparison with the figures of last year, there has ...
...ollections of liver tissue samples ever acquired b...esearchers have embarked on a massive study// of o...lcoholic fatty liver disease starts with the accum...lly fatal cirrhosis. If the damage becomes too gre...
...in Florida, USA, a 61-year-old woman caught shopli...e queue to pay her bill as she was suffering from ...able bowel syndrome seems to have been discovered ...d when she was caught shoplifting in Cape Coral, F...
Other Medicine News:Health News:UK Mental Health Reforms Will Do More Harm Than Good, Critics Warn 2Health News:Government Delivers On Emergency Medical Training For Rural Doctors 2Health News:Ethanol Could Be Damaging for Human Health, New Study Says 2Health News:Ethanol Could Be Damaging for Human Health, New Study Says 3Health News:Geisinger Launches Extensive Study on Obesity and Related Liver Problem 2
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: